Key result
A systematic approach guided by clinical symptoms with early administration of immunotherapy can lead to a significant reduction of morbidity and mortality in digoxin-poisoned patients.
Design
Review
Authors
Loading...
May support early immunotherapy in digoxin toxicity; leaves open prospective validation of mortality benefit.
Early administration of immunotherapy guided by clinical symptoms is crucial for reducing morbidity and mortality in digoxin toxicity.
Litonjua et al. (2005) conducted a review in Digoxin toxicity. Digoxin was evaluated. A systematic approach guided by clinical symptoms with early administration of immunotherapy can lead to a significant reduction of morbidity and mortality in digoxin-poisoned patients.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: